Hebing Zhou

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Case Report: Novel CXCR2 compound heterozygous variants in an infant with neutropenia.

Case Report: Novel CXCR2 compound heterozygous variants in an infant with neutropenia.

Journal: Frontiers in immunology

Published: April 02, 2026

Prognostic impact of monocyte percentage and extranodal involvement in classical hodgkin lymphoma: A multicenter real-world study of 547 chinese patients.

Prognostic impact of monocyte percentage and extranodal involvement in classical hodgkin lymphoma: A multicenter real-world study of 547 chinese patients.

Journal: Annals of hematology

Published: February 03, 2026

Modified treatment protocol for pediatric systemic lupus erythematosus-associated hemophagocytic lymphohistiocytosis with central nervous system involvement: a case report.

Modified treatment protocol for pediatric systemic lupus erythematosus-associated hemophagocytic lymphohistiocytosis with central nervous system involvement: a case report.

Journal: Frontiers in immunology

Published: January 26, 2026

Venetoclax combined with azacitidine for treatment of a blastic plasmacytoid dendritic cell neoplasm: A case report and literature review.

Venetoclax combined with azacitidine for treatment of a blastic plasmacytoid dendritic cell neoplasm: A case report and literature review.

Journal: Experimental and therapeutic medicine

Published: June 07, 2025

Azacitidine plus venetoclax for maintenance treatment in intermediate‑to‑low‑risk acute myeloid leukemia: A comparative analysis of clinical outcomes in an observational cohort.

Azacitidine plus venetoclax for maintenance treatment in intermediate‑to‑low‑risk acute myeloid leukemia: A comparative analysis of clinical outcomes in an observational cohort.

Journal: Oncology letters

Published: December 06, 2024

Immune-based subgroups uncover diverse tumor immunogenicity and implications for prognosis and precision therapy in acute myeloid leukemia.

Immune-based subgroups uncover diverse tumor immunogenicity and implications for prognosis and precision therapy in acute myeloid leukemia.

Journal: Frontiers in immunology

Published: June 19, 2024

Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.

Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.

Journal: BMC cancer

Published: April 12, 2023

Radiotherapy in Philadelphia chromosome‑positive acute lymphoblastic leukemia with pericardial invasion after transplantation: A case report.

Radiotherapy in Philadelphia chromosome‑positive acute lymphoblastic leukemia with pericardial invasion after transplantation: A case report.

Journal: Oncology letters

Published: December 27, 2022

Identification of Survival-Related Genes in Acute Myeloid Leukemia (AML) Based on Cytogenetically Normal AML Samples Using Weighted Gene Coexpression Network Analysis.

Identification of Survival-Related Genes in Acute Myeloid Leukemia (AML) Based on Cytogenetically Normal AML Samples Using Weighted Gene Coexpression Network Analysis.

Journal: Disease markers

Published: March 09, 2022

Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China.

Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China.

Journal: Cancer biology & medicine

Published: August 27, 2021

Immune prognostic risk score model in acute myeloid leukemia with normal karyotype.

Immune prognostic risk score model in acute myeloid leukemia with normal karyotype.

Journal: Oncology letters

Published: February 21, 2020

Antiproliferative effects of L-asparaginase in acute myeloid leukemia.

Antiproliferative effects of L-asparaginase in acute myeloid leukemia.

Journal: Experimental and therapeutic medicine

Published: September 25, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026